|
Drugs | Type of regulation | Mechanism | Cell lines/animal model | References |
|
Coptidis rhizome (CR) | Anticachectic | IL-6↓ | Esophageal cancer model | Iizuka et al. [14] |
BBR | Antiproliferation Proapoptosis | G2/M arrest↑ P21↑ Akt/mTOR↓ p-AMPK↑ | Human esophageal squamous carcinoma cell line KYSE-70 cells | Jiang et al. [11] |
BBR | Antiproliferation Anti-invasion | Cxc chemokine receptor 4 and Cxc chemokine receptor 7↓ | Esophageal cancer cells | Mishan et al. [15] |
BBR and galangin | Antiproliferation Proapoptosis | G2/M arrest↑ ROS↑Wnt3a ↓β-catenin↓ | Esophageal cancer cells/model | Ren et al. [16] |
BBR | Proradiosensitivity | VEGF and HIF-1α↓ | Esophageal squamous cell carcinoma | Yang et al. [17] |
BBR | Proradiosensitivity | RAD51↓ | Esophageal cancer cells | Liu et al. [18] |
BBR | Antiproliferation Antimigration | ROS↑NF-κB p65↓MMP-1 -2, and -9↓ | GC cells | Lin et al. [22] |
BBR | Proapoptosis | Caspase-3↑ cleaved poly ADP-ribose polymerase↑ The damage of mitochondrial membrane potential Akt/mTOR/p70S6/S6↓ | GC cells | Yi et al. [24] |
BBR | Antiproliferation | STAT3↓survivin↓ | Gastric adenocarcinoma cells | Pandey et al. [28] |
BBR and 5-FU | Antichemotherapy resistance | STAT3↓survivin↓ | Gastric adenocarcinoma cells | Pandey et al. [28] |
BBR | Antiproliferation Antimigration | COX-2/PGE2↓ p-JAK2↓p-STAT3↓MMP-2/-9↓ | CRC cells | Liu et al. [29] |
BBR | Antiproliferation | G2/M arrest↑ cyclin B1↓cdc2↓cdc25c↓ | Human colorectal adenocarcinoma cells | Cai et al. [30] |
BBR | Antiproliferation Proapoptosis | AMPK↑mTOR↓NF-κB↓cyclin D1↓survivin↓p-p53↑caspase-3↑ | Colorectal carcinogenesis mouse model CRC cells | Li et al. [31] |
BBR | Antiproliferation Proapoptosis | ATF3 ↑ NAG-1↑ | CRC cells | Piyanuch et al. [32] |
BBR | Antiproliferation Antitumorigenesis | TNF-α↓ IL-6↓in macrophages EGFR-ERK signaling↓ | Colitis-associated colorectal cancer (CACRC) mice model and RAW 264.7 macrophages and colon cancer HCT116 cells | Li et al. [33] |
BBR | Proautophagy | GRP78↑ | Colon cancer cells | La et al. [34] |
BBR | Antiglucose uptake Antiglucose metabolic | GLUT1↓LDHA↓HK2↓ HIF-1α protein↓ mTOR phosphorylation↓ | Colon cancer cells | Mao et al. [35] |
BBR | Anti-intestinal polyps | Wnt↓cyclin D1↓ c-Myc↓ | ApcMin/+ mice | Zhang et al. [36] |
BBR | Anti-intestinal polyps | β-Catenin signaling pathway↓ | Nude mice | Ruan et al. [37] |
BBR | Anticancer stem cells Antimetastasis | Cancer stem cells↓ SOX2↓, POU5F1↓, NANOG↓ | Pancreatic cancer cells | Park et al. [38] |
BBR | Antiproliferation Proapoptosis | G1/S arrest↑ ROS↑ | Pancreatic cancer cells | Park et al. [39] |
BBR | Antiproliferation Proapoptosis | Caspase-3↑caspase-7↑ BRCA1-mediated DNA damage↑ G1/S arrest ↑G2/M arrest↑ P53 signaling pathways ↑ | Pancreatic cancer cells | Pinto-Garcia et al. [40] |
BBR | Antiproliferation | G1/S arrest ↑ | Hamster cholangiocarcinoma (CCA) cells | Puthdee et al. [41] |
BBR | Antiproliferation | G0/G1 arrest ↑CDKIs p21Cip1↑ p27Kip1↑ | HCC cells | Li et al. [42] |
BBR | Promitochondrial impairment Proapoptosis | PHLPP2-Akt-MST1 kinase signaling pathway | HCC cells | Saxena et al. [43] |
BBR and sorafenib | Antiproliferation Proapoptosis | ADP-ribose polymerase↑ caspase-3↑ BCL-2↓VEGF↓ | HCC cells | Huang et al. [44] |
BBR and HMQ1611 (BCH) | Antiproliferation Antimigration | G1 phase arrest ↑ Wnt/β-catenin signaling pathway↓ | HCC cells | Dai et al. [45] |
BBR | Antiproliferation Proapoptosis | 347 miRNAs ↑ 93 miRNAs↓ 78 novel miRNAs were identified | GC cells | Yang et al. [46] |
BBR | Cisplatin sensitivity↑ Proapoptosis | miRNA-203↑Bcl-w↓ | GC cells | You et al. [49] |
BBR | Antiproliferation Antitumorigenesis | DNMT1↑, DNMT3A↑, DNMT3B↑ and miRNA-152↑, miRNA-429↑, miRNA-29a↑ | Colon cancer tissues | Huang et al. [50] |
BBR | Proapoptosis | miRNA-429↓ | Colorectal tissue | Liu et al. [52] |
BBR and NVP-AUY922 | Antiproliferation | CDK4↓miR-296↑Pin1-β-catenin-cyclin D1 signaling pathway↓ | Human colon adenocarcinoma cells | Su et al. [55] |
coptisine (COP) | Antiproliferation Antimigration Proapoptosis | miR-122↑ | HCC cells hepatocellular carcinoma nude mice | Chai et al. [56] |
BBR | Antiproliferation Proapoptosis | lncRNA CASC2↑BCL2↓ | CRC cells | Dai et al. [60] |
BBR | Antidevelopment of intestinal cancer modified gut microbiota’s structure | Akkermansia↓ Short chain fat acid (SCFA)-producing bacteria↑ | Multiple intestinal neoplasia mice | Wang et al. [64] |
BBR | Antigenesis of CRC induced by Fusobacterium nucleatum | Fusobacterium nucleatum↓ IL-21/22/31↓CD40L ↓p-STAT3↓, p-STAT5 ↓ p-ERK1/2↓ | Multiple intestinal neoplasia mice | Yu et al. [66] |
|